Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar NuclearSteve (< 20) Submitted: 12/29/2011 12:49:57 PM : Outperform Start Price: $1.82 ASTM Score: +7.63

Article from Zacks Biotech Guy - Jason Napodano - trying a strategy where I set 10% stops on all these and let the winners run.

Featured Broker Partners


Advertisement